Race Oncology

0 followers

‌

Race Oncology (ASX: RAC) is a precision oncology company with a Phase II/III cancer drug called Bisantrene.

Industries

Headquarters

Employees

Links

Org chart

Chief Medical Officer

Clinical Program Director

Program Management, Risk & Strategy Director

Principal Scientist

2 members

1 members

1 members

AFT Pharmaceuticals

1 follower

Boehringer Ingelheim

37 followers

Leo Pharma

27 followers

Mayne Pharma

1 follower

Blackmores

1 follower

Discover companies